Denosumab and Teriparatide Study (DATA-HD and DATA-EX)
Status:
Completed
Trial end date:
2020-02-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to assess the effect of an antiresorptive medication in combination
with standard dose or alternate dose teriparatide. The study extension will evaluate the
effect of one-dose of zoledronic acid after the teriparatide/denosumab combination.